Home Kleiner Perkins's Beth Seidenberg Says Immunotherapy Is Biotech Powerhouse
 

Keywords :   


Kleiner Perkins's Beth Seidenberg Says Immunotherapy Is Biotech Powerhouse

2015-03-24 05:50:52| Biotech - Topix.net

Investing in biotechnology is known to be tough, as startups often face years of development time, clinical trials and regulatory work before maturing to the point where they can offer returns for the investors. But Kleiner Perkins Caufield & Byers recently bucked that trend, reaping well over 10 times what it put into immunotherapy company Flexus Biosciences Inc. in less than a year and a half.

Tags: beth kleiner biotech powerhouse

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Registration Now Open for RadTech 2025
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
More »